GNC creatine serum
This article was originally published in The Tan Sheet
Executive Summary
Muscle Marketing USA objects to GNC marketing "shoddy imitation" of its Creatine Serum that "does not contain creatine phosphate complex" or absorb as easily into the body. In an Aug. 4 release, the Los Angeles-based firm insists GNC either rename the copycat product "or face legal action." GNC has agreed to change the name of its creatine product "as soon as their current inventory is exhausted," MMUSA reports. The firm filed a $150 mil. lawsuit against Degussa Bioactives for falsely advertising the safety of its Creapure creatine powder in July (1"The Tan Sheet" July 7, 2003, In Brief)....
You may also be interested in...
Natural Products Expo East In Brief
Nature's Way: Umcka ColdCare line of cough/cold homeopathic remedies launched at Natural Products Expo East in Washington, D.C. Sept. 5-7. Product is derived from Pelargonium sidoides, "a species of geranium unique to South Africa." Umcka carries the claim: "shortens duration of throat, sinus and bronchial irritations." Nature's Way reports that sales of the product are seven times 2001 sales in Germany. Umcka comes in 1 oz. original or alcohol-free drops and 4 oz. menthol or cherry syrup flavors for a retail price of $12.99...
Creatine lawsuit
Muscle Marketing USA, which distributes Creatine Serum, files $150 mil. lawsuit July 3 against Degussa Bioactives for unlawful and unfair business practices, false advertising and unlawful concealment of facts relating to the firm's Creapure powder. MMUSA alleges Degussa's ads misrepresent facts about creatine by telling consumers Creapure is safe, "even though it is associated with ailments ranging from stomach cramps to dehydration." Firm further contends that since 1999, Degussa "has repeatedly attempted to misappropriate information about the chemical formulation and nature of Creatine Serum," which is a liquid form of creatine marketed to athletes. 1MMUSA's Web site maintains Creatine Serum is safer than powders because small doses "have the equivalent benefits of large amounts of powder"...
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.